Evolent Health, Inc (EVH): Price and Financial Metrics
EVH Price/Volume Stats
| Current price | $29.26 | 52-week high | $36.70 |
| Prev. close | $30.13 | 52-week low | $23.33 |
| Day low | $28.96 | Volume | 1,024,300 |
| Day high | $30.29 | Avg. volume | 946,889 |
| 50-day MA | $31.84 | Dividend yield | N/A |
| 200-day MA | $29.38 | Market Cap | 3.38B |
EVH Stock Price Chart Interactive Chart >
Evolent Health, Inc (EVH) Company Bio
Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.
Latest EVH News From Around the Web
Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To PersistThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a... |
How Much Upside is Left in Evolent Health (EVH)? Wall Street Analysts Think 59.66%The consensus price target hints at a 59.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Insider Sell: CEO Seth Blackley Sells 141,000 Shares of Evolent Health Inc (EVH)In a notable insider transaction, CEO Seth Blackley has sold 141,000 shares of Evolent Health Inc (NYSE:EVH) on December 5, 2023. |
Evolent Health Looks to Start an Advance, But When?Evolent Health, Inc. was rated a new market outperform (buy) at JMP Securities with a $37 price target. Evolent provides "an integrated administrative and clinical platform for health plan administration and population health management". In this daily bar chart of EVH, below, I can see that prices have made a choppy decline since April. |
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term LoanEvolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the |
EVH Price Returns
| 1-mo | -8.93% |
| 3-mo | -3.30% |
| 6-mo | 22.02% |
| 1-year | -16.92% |
| 3-year | 38.08% |
| 5-year | 114.05% |
| YTD | -11.41% |
| 2023 | 17.63% |
| 2022 | 1.48% |
| 2021 | 72.61% |
| 2020 | 77.13% |
| 2019 | -54.64% |
Continue Researching EVH
Want to do more research on Evolent Health Inc's stock and its price? Try the links below:Evolent Health Inc (EVH) Stock Price | Nasdaq
Evolent Health Inc (EVH) Stock Quote, History and News - Yahoo Finance
Evolent Health Inc (EVH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...